| Role of α5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice KJ Jackson, MJ Marks, RE Vann, X Chen, TF Gamage, JA Warner, ... Journal of Pharmacology and Experimental Therapeutics 334 (1), 137-146, 2010 | 170 | 2010 |
| Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol RE Vann, TF Gamage, JA Warner, EM Marshall, NL Taylor, BR Martin, ... Drug and alcohol dependence 94 (1-3), 191-198, 2008 | 140 | 2008 |
| Molecular and behavioral pharmacological characterization of abused synthetic cannabinoids MMB-and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA TF Gamage, CE Farquhar, TW Lefever, JA Marusich, RC Kevin, ... Journal of Pharmacology and Experimental Therapeutics 365 (2), 437-446, 2018 | 74 | 2018 |
| In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569 TF Gamage, BM Ignatowska-Jankowska, JL Wiley, M Abdelrahman, ... Behavioural pharmacology 25 (2), 182-185, 2014 | 68 | 2014 |
| Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice D Ramesh, TF Gamage, T Vanuytsel, RA Owens, RA Abdullah, ... Neuropsychopharmacology 38 (6), 1039-1049, 2013 | 63 | 2013 |
| Sex, THC, and hormones: Effects on density and sensitivity of CB1 cannabinoid receptors in rats CE Farquhar, CS Breivogel, TF Gamage, EA Gay, BF Thomas, RM Craft, ... Drug and alcohol dependence 194, 20-27, 2019 | 61 | 2019 |
| The endocannabinoid system: role in energy regulation TF Gamage, AH Lichtman Pediatric blood & cancer 58 (1), 144-148, 2012 | 48 | 2012 |
| Synthetic cannabinoid hydroxypentyl metabolites retain efficacy at human cannabinoid receptors TF Gamage, CE Farquhar, RJ McKinnie, RC Kevin, IS McGregor, ... Journal of Pharmacology and Experimental Therapeutics 368 (3), 414-422, 2019 | 43 | 2019 |
| Thermolytic degradation of synthetic cannabinoids: chemical exposures and pharmacological consequences BF Thomas, TW Lefever, RA Cortes, M Grabenauer, AL Kovach, AO Cox, ... Journal of Pharmacology and Experimental Therapeutics 361 (1), 162-171, 2017 | 43 | 2017 |
| Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice TF Gamage, BM Ignatowska-Jankowska, PP Muldoon, BF Cravatt, ... Drug and alcohol dependence 146, 7-16, 2015 | 40 | 2015 |
| Sex, species and age: Effects of rodent demographics on the pharmacology of∆ 9-tetrahydrocanabinol JL Wiley, DG Barrus, CE Farquhar, TW Lefever, TF Gamage Progress in Neuro-Psychopharmacology and Biological Psychiatry 106, 110064, 2021 | 34 | 2021 |
| Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN … RC Kevin, AL Kovach, TW Lefever, TF Gamage, JL Wiley, IS McGregor, ... Forensic toxicology 37, 17-26, 2019 | 33 | 2019 |
| The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB1 receptor allosteric modulators TF Gamage, CE Farquhar, TW Lefever, BF Thomas, T Nguyen, Y Zhang, ... Neuropharmacology 125, 365-375, 2017 | 25 | 2017 |
| Novel diarylurea based allosteric modulators of the cannabinoid cb1 receptor: Evaluation of importance of 6-pyrrolidinylpyridinyl substitution T Nguyen, N German, AM Decker, TL Langston, TF Gamage, ... Journal of medicinal chemistry 60 (17), 7410-7424, 2017 | 24 | 2017 |
| L-theanine attenuates abstinence signs in morphine-dependent rhesus monkeys and elicits anxiolytic-like activity in mice LE Wise, ID Premaratne, TF Gamage, AH Lichtman, LD Hughes, ... Pharmacology Biochemistry and Behavior 103 (2), 245-252, 2012 | 23 | 2012 |
| CB1 Allosteric Modulator Org27569 Is an Antagonist/Inverse Agonist of ERK1/2 Signaling TF Gamage, JC Anderson, ME Abood Cannabis and Cannabinoid Research 1 (1), 272-280, 2016 | 21 | 2016 |
| The endogenous cannabinoid anandamide shares discriminative stimulus effects with∆ 9-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice DM Walentiny, TF Gamage, JA Warner, TK Nguyen, DB Grainger, ... European journal of pharmacology 656 (1-3), 63-67, 2011 | 19 | 2011 |
| Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN‐18 RC Kevin, TW Lefever, RW Snyder, PR Patel, TF Gamage, TR Fennell, ... Drug testing and analysis 10 (1), 137-147, 2018 | 15 | 2018 |
| Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats MJ Wright Jr, RE Vann, TF Gamage, MI Damaj, JL Wiley Pharmacology Biochemistry and Behavior 85 (3), 507-513, 2006 | 15 | 2006 |
| In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018 TF Gamage, DG Barrus, RC Kevin, DB Finlay, TW Lefever, PR Patel, ... Pharmacology Biochemistry and Behavior 193, 172918, 2020 | 12 | 2020 |
